114 related articles for article (PubMed ID: 2124997)
1. Measurement of tissue cholecystokinin (CCK) concentrations by bioassay and specific radioimmunoassay: characterization of the bioactivity of CCK-58 before and after tryptic cleavage.
Höcker M; Schmidt WE; Wilms HM; Lehnhoff F; Nustede R; Schafmayer A; Fölsch UR
Eur J Clin Invest; 1990 Oct; 20 Suppl 1():S45-50. PubMed ID: 2124997
[TBL] [Abstract][Full Text] [Related]
2. Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay.
Mössner J; Zeeh JM; Eberlein G; Schäffer M; Regner U; Grandt D; Goebell H; Eysselein VE
Digestion; 1991; 48(4):210-9. PubMed ID: 1724764
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR
Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514
[TBL] [Abstract][Full Text] [Related]
4. Measurement and characterisation of human cholecystokinin-like immunoreactivity (CCK-LI) in tissues by radioimmunoassay.
Bacarese-Hamilton AJ; Adrian TE; Bloom SR
Clin Chim Acta; 1984 Dec; 144(2-3):213-24. PubMed ID: 6529856
[TBL] [Abstract][Full Text] [Related]
5. Biologic and radioimmunologic activity of cholecystokinin in regions of mammalian brains.
Simon-Assmann PM; Yazigi R; Greeley GH; Rayford PL; Thompson JC
J Neurosci Res; 1983; 10(2):165-73. PubMed ID: 6313953
[TBL] [Abstract][Full Text] [Related]
6. Large molecular forms of cholecystokinin circulating in humans.
Gaisano HY; Reilly W; Go VL; Olivero D; Miller LJ
Pancreas; 1986; 1(2):148-53. PubMed ID: 2437562
[TBL] [Abstract][Full Text] [Related]
7. Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques.
Bacarese-Hamilton AJ; Adrian TE; Chohan P; Bloom SR
Regul Pept; 1985 Jun; 11(2):149-58. PubMed ID: 4035007
[TBL] [Abstract][Full Text] [Related]
8. [Basal plasma cholecystokinin levels in digestive diseases--comparison between CCK-8 like bioactivity by bioassay and CCK immunoreactivity by radioimmunoassay].
Nakamura R; Miyasaka K; Funakoshi A; Kitani K; Kuyama Y; Goseki N; Kino K; Tsuru M; Fukazawa T
Nihon Shokakibyo Gakkai Zasshi; 1989 Nov; 86(11):2572-8. PubMed ID: 2601119
[TBL] [Abstract][Full Text] [Related]
9. Immunological evidence of cholecystokinin-39 in porcine brain.
Jansen JB; Lamers CB
Life Sci; 1983 Feb; 32(8):911-3. PubMed ID: 6827917
[TBL] [Abstract][Full Text] [Related]
10. Bioassayable cholecystokinin in the brain of the goldfish, Carassius auratus.
Sankaran H; Wong A; Khan SJ; Peeke HV; Raghupathy E
Neuropeptides; 1987; 9(2):103-11. PubMed ID: 3574607
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.
Liddle RA; Goldfine ID; Rosen MS; Taplitz RA; Williams JA
J Clin Invest; 1985 Apr; 75(4):1144-52. PubMed ID: 2580857
[TBL] [Abstract][Full Text] [Related]
12. Effect of chymotrypsin on human cholecystokinin release: use of clostripain in the validation of a new radioimmunoassay.
Beardshall K; Deprez P; Playford RJ; Alexander M; Calam J
Regul Pept; 1992 Jul; 40(1):1-12. PubMed ID: 1438974
[TBL] [Abstract][Full Text] [Related]
13. Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini.
Miyasaka K; Funakoshi A; Matsumoto M; Nakamura R; Sakamoto S; Sakai H; Kitani K
Dig Dis Sci; 1991 Mar; 36(3):310-6. PubMed ID: 1995267
[TBL] [Abstract][Full Text] [Related]
14. Peptides in rat brain immunoreactive for the carboxyl terminal extension of cholecystokinin: distribution and chromatography.
Beinfeld MC
Peptides; 1985; 6(5):857-60. PubMed ID: 4080606
[TBL] [Abstract][Full Text] [Related]
15. Differential distribution of molecular forms of cholecystokinin in human and porcine small intestinal mucosa.
Maton PN; Selden AC; Chadwick VS
Regul Pept; 1984 Jan; 8(1):9-19. PubMed ID: 6718767
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin in pig plasma: release of components devoid of a bioactive COOH-terminus.
Cantor P; Rehfeld JF
Am J Physiol; 1989 Jan; 256(1 Pt 1):G53-61. PubMed ID: 2912150
[TBL] [Abstract][Full Text] [Related]
17. Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract.
Bacarese-Hamilton AJ; Adrian TE; Bloom SR
Regul Pept; 1984 Nov; 9(4):289-98. PubMed ID: 6522644
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the major form of cholecystokinin in human intestine: CCK-58.
Eysselein VE; Eberlein GA; Schaeffer M; Grandt D; Goebell H; Niebel W; Rosenquist GL; Meyer HE; Reeve JR
Am J Physiol; 1990 Feb; 258(2 Pt 1):G253-60. PubMed ID: 2305892
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine.
Eberlein GA; Eysselein VE; Goebell H
Peptides; 1988; 9(5):993-8. PubMed ID: 3244567
[TBL] [Abstract][Full Text] [Related]
20. The subcellular distribution of peptides immunoreactive for the carboxyl-terminal extension of cholecystokinin in rat brain.
Allard LR; Beinfeld MC
Neuropeptides; 1985 Jun; 6(3):239-45. PubMed ID: 4022279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
